Affymetrix (NASDAQ:AFFX) sees its Q3 revenue at $18 million due to its eBioscience business. The company thinks that its complete revenue for Q3 saw a negative impact by a tightening academic funding environment worldwide, which mostly affects the company’s gene expression and eBioscience business units. The shares closed at $3.71, down $0.6 or 13.92% on the day. They have traded in a 52-week range of $3.52 to $5.95.
Ezcorp (NASDAQ:EZPW) revealed late Thursday that Stephen Stamp, its Chief Financial Officer, is resigning from the company beginning October 5. Stamp did not leave due to any issue or concern with the company’s accounting, financial reporting, or internal control regarding financial reporting, according to the company. Mark Kuchenrither, executive vice president, is to take the role of CFO effective October 5. Beginning on October 5, Kuchenrither’s role in the company will be will be executive vice president and Chief Financial Officer of EZCORP and President of Change Capital. The shares closed at $20.39, down $1.52 or 6.94% on the day. They have traded in a 52-week range of $21.39 to $33.38.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>